SCHEMBL2225329

SCHEMBL2225329

C#Cc1cccc(Nc2cc(NCc3cc(S(N)(=O)=O)ccc3SC)ncn2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.45
ERBB3 P21860 2/20 0.45
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNA2 P20248 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CCNT1 O60563 1/20 0.40
CDK9 P50750 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
TNNI3K Q59H18 11/20 0.39
KDR P35968 1/20 0.35
ROCK1 Q13464 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225212 0.86 EGFR (0.46) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2226143 0.83 CCNA2 (0.47) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2227241 0.81 CDK1 (0.46) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2227638 0.81 TNNI3K (0.57) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2226099 0.80 IRAK4 (0.44) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2226860 0.80 TNNI3K (0.45) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2224279 0.80 EGFR (0.53) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2228558 0.79 CDK2 (0.43) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2226407 0.79 TNNI3K (0.42) EGFRERBB3CDK1CCNB1CCNA2
SCHEMBL2224234 0.79 TNNI3K (0.43) EGFRERBB3CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed